New England Journal of Medicine
It’s long been known that faulty BRCA genes greatly raise the risk for breast cancer. Now scientists say a more recently identified, less common gene can do the same.
In the midst of the diabetes epidemic, a glimmer of good news: Heart attacks, strokes and other complications from the disease are plummeting.
Help yourself to some nuts this holiday season. According to a new study, regular nut eaters were less likely to die of cancer or heart disease — in fact, were less likely to die of any cause.
Researchers have discovered the first U.S. cases of whooping cough caused by a germ that may be resistant to the vaccine.
Researchers who reviewed the science behind some widely held obesity beliefs found it lacking. Their report says dogma and fallacies are detracting from real solutions to the nation’s weight problems.
A new study shows how important it is for men to carefully consider treatments for early-stage prostate cancer. Fifteen years after surgery or radiation treatment, nearly all of the older men in the study had some problems having sex.
Cynthia Wilson of Dallas didn’t walk through the doors of a Planned Parenthood clinic looking for contraception
Until now, the Medicaid debate has been about budgets and states’ rights. But a statistical study found a 6 percent drop in the adult death rate in three states that have recently expanded coverage for low-income residents along the general lines of the federal health care law.
Ten months after becoming the first person to get a full face transplant in the United States, a Fort Worth man marvels at recovering the ability of expression.
In what’s being called a landmark study, researchers using gene therapy have successfully treated six patients with severe hemophilia B, a blood-clotting disorder.
A new safety study is helping ease the minds of millions of parents who have children with Attention Deficit-Hyperactivity Disorder, or ADHD.
Scientists are reporting the first clear success with a new approach for treating leukemia — turning the patients’ own blood cells into assassins that hunt and destroy their cancer cells.